Atlas Trials

A Study to Determine the Safety and Efficacy of Atralin (Tretinoin 0.05%) Gel for the Treatment of Rosacea

Clinical trial NCT00621218 · COMPLETED

Trial details

NCT number
NCT00621218
Sponsor
Coria Laboratories, Ltd.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Rosacea
Start date
2008-02-01
Primary completion
2008-04-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.